Retatrutide has emerged as a new treatment in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By stimulating these receptors, Retatrutide controls cravings, {promotesglucose regulation, and ulti